To Evaluate the Safety, Tolerability and to Compare the Pharmacokinetic Profile of ATX-101
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The objectives of this trial are to evaluate the safety and tolerability of ATX-101
injections and to compare the pharmacokinetic profile of ATX-101 administered into
subcutaneous fat in the submental area and abdomen.